Metropolitan Bank SEC Filings

Alset Inc. (AEI) 8-K: On 23 Jul 2025 the company closed its purchase of New Energy Asia Pacific Inc. (NEAPI) from Chairman/CEO Chan Heng Fai for an $83 m, 1% promissory note convertible at $3.00 per share. Immediately after closing, Chan converted the entire note into 27.67 m restricted AEI shares, retiring the debt.

NEAPI owns 41.5 % of Hong-Kong based New Energy Asia Pacific Co., a distributor of all-electric specialty vehicles, charging stations and batteries. Management calls the deal a strategic push into sustainable transport, citing signed MOUs and “strong interest” from Asian municipal customers that could drive near-term revenue growth.

The all-stock consideration increases AEI’s outstanding share count and further concentrates insider ownership. Because the seller is AEI’s largest shareholder, the transaction is a related-party deal; the share issuance relied on the Section 4(a)(2) private-placement exemption.

Form 4 overview: On 22 Jul 2025, Maiken Keson-Brookes, Chief Legal Officer & Secretary of Mural Oncology plc (MURA), sold 2,572 ordinary shares at a weighted-average price of $2.48 (price band $2.46-$2.51). The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on 20 Sep 2024.

Following the transaction, the insider directly owns 68,834 shares, which include 62,203 unvested RSUs. No derivative securities were reported and no other insiders participated. The filing indicates direct ownership status and contains the standard acknowledgements and signatures required under Section 16.

Metropolitan Bank Holding Corp. (MCB) filed a Form 144 indicating an insider’s intention to sell up to 1,400 common shares through Fidelity Brokerage on the NYSE. Based on the filing’s stated market value of $111,020, the proposed transaction equals roughly 0.013 % of the company’s 10,660,109 shares outstanding, suggesting minimal market impact. The shares were originally acquired via open-market purchases—1,000 shares on 05/13/2022 and 400 shares on 03/13/2023—and are slated for sale on or after 07/22/2025. The filer reports no sales in the past three months and certifies awareness of no undisclosed adverse information. While quantitatively small, the notice provides transparency into insider activity and may be monitored by investors tracking sentiment.

Metropolitan Bank Holding Corp. (MCB) filed a Form 144 signaling a prospective insider sale. Seller: Scott Lublin. Planned sale: up to 5,000 common shares through Fidelity Brokerage Services on or about 21 Jul 2025. Based on the indicated price, the transaction is valued at $393,222. With 10.66 million shares outstanding, the notice covers roughly 0.05 % of the float, a de-minimis level.

The shares originated from a restricted-stock vesting event on 18 Mar 2021 and were received as compensation. The filer already disposed of 5,000 shares on 20 Jun 2025, generating gross proceeds of $325,126. Form 144 is a notification only; the full amount may or may not be sold.

Because of the transaction’s small size and routine nature, the filing is unlikely to be materially impactful for most investors, but it provides incremental insight into the insider’s liquidity actions and potential sentiment.

Metropolitan Bank Holding Corp. (MCB) – Form 4 insider trading report. Executive Vice President Nick Rosenberg sold 1,250 common shares of MCB on 07/03/2025 at a weighted-average price of $75.0516 under a pre-arranged Rule 10b5-1 trading plan adopted on 06/06/2024. The sale represents roughly 4% of his directly held shares.

Following the transaction, Rosenberg still owns 29,589 shares directly as well as 750 shares held indirectly for three children. His remaining direct holdings include restricted stock units (RSUs) granted on 03/01/2023, 03/01/2024 and 03/01/2025 that vest in equal thirds over three years beginning 03/01/2024, 03/01/2025 and 03/01/2026, respectively. No derivative securities were reported as exercised or disposed.

The filing discloses no additional purchases, option exercises or other material events. Because the sale was executed pursuant to a 10b5-1 plan, it may be viewed as routine portfolio management rather than a discretionary sale. Investors may monitor future filings to gauge ongoing insider sentiment.

Metropolitan Bank Holding Corp. (NYSE: MCB) – Form 144 insider selling notice

The filing reveals an intended sale of 1,250 common shares—about 0.012 % of the 10,660,109 shares outstanding—with an aggregate market value of $91,512.50 (≈ $73.21 per share). J.P. Morgan Securities LLC will act as broker, and the transaction is slated for on-exchange execution on or after 3 July 2025 (NYSE).

The shares were originally granted as executive compensation in three tranches dated 12-31-2019, 01-01-2020 and 03-01-2021. The filer reports no sales in the preceding three months. By signing Form 144, the seller certifies that he/she possesses no undisclosed material adverse information regarding the issuer.

Investor implications

• Transaction size is immaterial to float and volume, so market impact should be minimal.
• Nonetheless, any insider disposition can be interpreted as a modest sentiment check, especially if followed by further sales.
• The use of Rule 144 suggests routine liquidity management rather than an immediate strategic change at the corporate level.

Metropolitan Bank Holding Corp (MCB) EVP and Chief Lending Officer Scott Lublin reported insider sales transactions executed on June 20, 2025, under a pre-established Rule 10b5-1 trading plan from March 18, 2025.

Key transaction details:

• Sold 4,956 shares at weighted average price of $65.0195 (range: $64.52-$65.4952)
• Sold additional 44 shares at weighted average price of $65.6453 (range: $65.5899-$65.7378)
• Following transactions, Lublin holds 51,179 shares directly

Remaining holdings include multiple restricted stock unit (RSU) grants from 2023-2025 with various vesting schedules, including performance-based RSUs granted May 30, 2024, vesting in thirds from June 2025 through February 2027.